Solitary plasmacytoma

The VA rates Solitary plasmacytoma under Diagnostic Code 7724 at 100%. The minimum 100% rating requires: Solitary plasmacytoma, when there is active disease or during a treatment phase. The maximum 100% rating requires: Solitary plasmacytoma, when there is active disease or during a treatment phase.

The VA rates Solitary plasmacytoma under Diagnostic Code (DC) 7724, governed by 38 CFR 38 CFR § 4.117. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.

Veterans rated for Solitary plasmacytoma may qualify for TDIU if the condition — alone or in combination with other service-connected disabilities — prevents substantially gainful employment. A single disability rated at 60% or higher (or multiple disabilities combining to 70%, with one at 40%) can support a TDIU claim under 38 CFR § 4.16.

Service connection for Solitary plasmacytoma requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease, and (3) a medical nexus linking the current diagnosis to that in-service occurrence. A nexus letter from a treating or independent medical examiner is the most reliable nexus evidence.

A Compensation & Pension (C&P) exam for Solitary plasmacytoma uses a Disability Benefits Questionnaire (DBQ) specific to the body system involved. The examiner documents the frequency, severity, and functional impact of your symptoms. Bring all relevant treatment records and be prepared to describe your worst-day symptoms — the examiner rates your condition based on the full clinical picture, not a single visit.